Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.5K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.5K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

3.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.0K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

3.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

3.3K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.3K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.7K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

4.4K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-carbon therapeutics in cardiorespiratory medicine: Integrating environmental health into clinical decision-making.

Respiratory medicine and research·2026
Same author

Impact of Immune Checkpoint Inhibitor-Combined Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer With Brain Metastases.

Clinical lung cancer·2026
Same author

Organized Lung Cancer Screening of Subjects Occupationally Exposed to Lung Carcinogens: The LUng Cancer Screening Occupational exposure Study Entry Findings.

JTO clinical and research reports·2026
Same author

Treatment Sequencing and Immunotherapy Rechallenge in Advanced Non-Small-Cell Lung Cancer: Final 24-Month Real-World Results from the French LIST Study.

Oncology and therapy·2026
Same author

Pulmonary nodules in a histoplasmosis-endemic area: Diagnostic challenges and lessons from a case series.

Respiratory medicine and research·2026
Same author

Increasing propellant gas emissions from pressurized metered-dose inhalers in obstructive lung diseases in France over 11 years.

Respiratory research·2026
Same journal

Family cohesion and adaptability in heart failure: an APIMeM analysis of symptom perception and spousal caregiving on patient self-care.

Frontiers in medicine·2026
Same journal

Prognostic factors analysis of surgical resection after conversion therapy for isolated pleural metastatic lung cancer: a retrospective analysis.

Frontiers in medicine·2026
Same journal

Case Report: a novel non-canonical splice site variant in COL4A5 in a patient with Alport syndrome.

Frontiers in medicine·2026
Same journal

Minimally invasive percutaneous cannulated screw fixation for pelvic fractures: a retrospective case cohort study of clinical and radiological outcomes.

Frontiers in medicine·2026
Same journal

A case analysis of Gitelman syndrome complicated with Sjögren's disease.

Frontiers in medicine·2026
Same journal

Inflammatory phenotyping by latent class analysis and machine learning-based prediction of postoperative complications in pediatric appendicitis: a retrospective cohort study.

Frontiers in medicine·2026
See all related articles

Related Experiment Video

Updated: Oct 6, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

11.1K

Women's COPD.

Maéva Zysman1,2, Chantal Raherison-Semjen2,3

  • 1Centre de Recherche cardio-thoracique de Bordeaux, Université de Bordeaux, Pessac, France.

Frontiers in Medicine
|January 20, 2022
PubMed
Summary
This summary is machine-generated.

Chronic obstructive pulmonary disease (COPD) now affects men and women equally, becoming a leading cause of death in women. Women experience more severe symptoms and poorer quality of life, necessitating improved disease management.

Keywords:
chronic obstructive pulmonary disease (COPD)epidemiologygenderperspectivesmoking

More Related Videos

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
05:34

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders

Published on: August 18, 2023

2.6K
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

975

Related Experiment Videos

Last Updated: Oct 6, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

11.1K
Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
05:34

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders

Published on: August 18, 2023

2.6K
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

975

Area of Science:

  • Pulmonary Medicine
  • Epidemiology
  • Women's Health

Background:

  • Chronic obstructive pulmonary disease (COPD) prevalence is equal in men and women since 2008.
  • Increased exposure to tobacco and biomass fuels contributes to COPD in women.
  • COPD is the leading cause of death for women in the USA.

Purpose of the Study:

  • To highlight the increasing burden of COPD in women.
  • To discuss the unique clinical presentation and challenges in managing COPD in women.
  • To advocate for improved global disease management strategies for women with COPD.

Main Methods:

  • Review of epidemiological data on COPD prevalence and mortality in women.
  • Analysis of clinical presentation differences between sexes.
  • Evaluation of treatment efficacy and healthcare access disparities.

Main Results:

  • Women exhibit higher susceptibility to smoking and pollutants.
  • Clinical presentation in women includes more breathlessness, anxiety, depression, lung cancer, undernutrition, and osteoporosis.
  • Quality of life is significantly more impaired in women.
  • Standard COPD medications show similar efficacy in both sexes for exacerbation prevention and lung function.

Conclusions:

  • There is an urgent need to recognize the growing burden of COPD in women.
  • Differences in susceptibility, clinical presentation, and quality of life require tailored management approaches.
  • Addressing under-diagnosis, under-testing (spirometry), and under-consultation is crucial for improving COPD care in women.